Showing results (41-50 of 532) with videos related to
Sort By:
Pageof 54
Current Pharmaceutical Design|April 3, 2001
Prostaglandins and lipid modificationG Sobal, H SinzingerApplied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 28, 2001
Methylene blue-enhanced stability of (99mTc)HMPAO and simplified quality control--a comparative investigationG Sobal, H SinzingerAnnals of the New York Academy of Sciences|January 17, 1995
Evidence for lipid regression in humans in vivo performed by 123iodine-low-density lipoprotein scintiscanningC Pirich, H SinzingerWiener Klinische Wochenschrift|July 15, 1988
[Liver function parameters and fibrinogen in intra-arterial and intravenous PGE1 infusion]H Sinzinger, P FitschaWiener Klinische Wochenschrift|January 1, 1991
[Prostaglandin E1 in therapy of peripheral arterial occlusive disease]H Sinzinger, W RogattiProstaglandins, Leukotrienes, and Medicine|May 1, 1986
Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteersE Pohanka, H SinzingerWiener Klinische Wochenschrift|January 1, 1995
Atherosclerotic lesions in humans--plaque stabilization and regressionH Kritz, H SinzingerWiener Klinische Wochenschrift|January 1, 1996
Passive smoking, platelet function and atherosclerosisH Kritz, H SinzingerVASA. Zeitschrift Fur Gefasskrankheiten|November 18, 2011
"Aspirin - resistance"? A few critical considerations on definition, terminology, diagnosis, clinical value, natural course of atherosclerotic disease, and therapeutic consequencesR Berent, H SinzingerArchives of Gynecology and Obstetrics|January 1, 1988
Reduced biological half-life of plasma prostacyclin in pre-eclampsiaH Sinzinger, G WeberPageof 54